DNAgo specializes in advanced genetic testing and cell banking services, focusing on rare genetic diseases and overall health management. Their genetic testing covers over 20,000 genes, allowing for the diagnosis of more than 7,000 rare diseases, including conditions like cystic fibrosis and hereditary cancers. Utilizing whole exome sequencing, DNAgo decodes nearly all gene regions, which enhances the diagnostic yield by identifying genetic variants associated with various symptoms. To streamline the interpretation of these variants, DNAgo has developed an AI-driven system called EVIDENCE, which adheres to established guidelines and significantly reduces the time and cost associated with variant analysis.

In addition to genetic testing, DNAgo offers cell banking services that include the storage of dermal papilla cells, NK cells, and stem cells. These services are designed to prepare individuals for future medical treatments and health management. The dermal papilla cells are particularly aimed at addressing hair loss, while NK cells and stem cells are stored for potential therapeutic applications against diseases and injuries. By integrating cutting-edge cell culture technology and research, DNAgo positions itself as a leader in personalized health solutions, enabling clients to proactively manage their health and wellness through genetic insights and advanced cell therapies.

United States

Diagnostic testing for patients across all rare genetic diseases, including Cystic fibrosis, Fabry disease, Epilepsy, Hemophilia, all types of hereditary cancers, and cell and gene therapy.

DNAgo

Company Details